CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 276 enrolled
Drug / intervention
Twelve Step Facilitation +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00018655
NCT00018655Phase 2Completed

Integrated Intervention for Substance Abusers With Depressive Disorders

VA Office of Research and Development·interventional·Posted Jul 5, 2001·Updated Apr 19, 2019

In Brief

A Phase 2 clinical trial evaluating Twelve Step Facilitation and Integrated Cognitive Behavioral Treatment for Substance-Related Disorders and Depressive Disorder. Completed, enrolled 276 participants across 1 site.

Detailed Summary

This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressive disorders versus the most commonly administered form of therapy for substance use disorders and depression, Twelve Step Facilitation (AA/NA model) group treatment plus medications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 5, 2001
Enrollment StartApr 1, 2000
Primary CompletionSep 1, 2009
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9.4 yearsPosted 25.0 years ago

Interventions

Twelve Step Facilitationbehavioral

Twelve Step Facilitation Therapy involves focusing on topics from 12-Step programs which support sobriety goals and personal growth.

Integrated Cognitive Behavioral Treatmentbehavioral

Integrated Cognitive Behavioral Treatment involves focusing on thoughts, activities, and interactions with people related to depressive symptoms and/or substance use.